Showing results (131-140 of 182) with videos related to
Sort By:
Pageof 19
BJOG : an International Journal of Obstetrics and Gynaecology|April 25, 2023
Transvenous occlusion of incompetent pelvic veins to treat chronic pelvic pain in women: A randomised controlled trialVivak Hansrani, David Riding, Mourad W Seif, et al.Frontiers in Oncology|March 14, 2019
A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer Population: Cheap as NGS Chips?Neil A J Ryan, Niall J Davison, Katherine Payne, et al.Rheumatology (Oxford, England)|September 1, 2016
A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practiceMeghna Jani, Sean Gavan, Hector Chinoy, et al.Journal of Community Genetics|January 9, 2015
Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHSMark Harrison, Stephen Birch, Martin Eden, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 10, 2023
Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque PsoriasisLeila G Lackey, Xinyi Ng, Jorien Veldwijk, et al.BMJ Open|September 21, 2023
Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UKAlexander Thompson, Ji-Hee Youn, Bruce Guthrie, et al.Ophthalmology Science|May 1, 2026
Patterns of X-Linked Retinitis Pigmentosa Genetic Testing in England and Implications for Service ProvisionSol Yates, William Whittaker, Mark Harrison, et al.Journal of Personalized Medicine|March 25, 2022
Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary CareMatthew Jones, Ralph K Akyea, Katherine Payne, et al.Journal of Clinical Epidemiology|November 28, 2024
Patient-reported outcomes and measures are under-utilised in advanced therapy medicinal products trials for orphan conditionsAndrada Ciuca, Siddharth Banka, Tara Clancy, et al.The Lancet. Healthy Longevity|June 8, 2021
Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort studyShona Livingstone, Daniel R Morales, Peter T Donnan, et al.Pageof 19